Treatment of hind limb ischemia using angiogenic peptide nanofibers

Biomaterials

Volumn 98, Issue , 2016, Pages 113-119

  Kumar, Vivek A ^a   Liu, Qi ^b   Wickremasinghe, Navindee C ^a   Shi, Siyu ^a   Cornwright, Toya T ^b   Deng, Yuxiao ^b   Azares, Alon ^b   Moore, Amanda N ^a   Acevedo Jake, Amanda M ^a   Agudo, Noel R ^c   Pan, Su ^b   Woodside, Darren G ^b   Vanderslice, Peter ^b   Willerson, James T ^b   Dixon, Richard A ^b   Hartgerink, Jeffrey D ^a  

^a Rice University   (United States)

^b TEXAS HEART INSTITUTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Hind limb ischemia; Multi domain peptide; Peripheral artery disease; Self assembly; Therapeutic angiogenesis

Indexed keywords

BLOOD VESSELS; CELL ENGINEERING; GENE THERAPY; GENES; HYDROGELS; MAMMALS; MOLECULAR BIOLOGY; NANOFIBERS; PEPTIDES; SCAFFOLDS (BIOLOGY); SELF ASSEMBLY; STEM CELLS; TISSUE; TISSUE ENGINEERING;

CELL TRANSPLANTATION; HIND LIMBS; MICROVASCULAR TISSUE ENGINEERINGS; MULTI DOMAINS; PERIPHERAL ARTERY DISEASE; PRO-ANGIOGENIC THERAPIES; REGENERATIVE MEDICINE; THERAPEUTIC ANGIOGENESIS;

DISEASES;

ANGIOGENIC PROTEIN; PEPTIDE; NANOFIBER;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SYNTHESIS; HOST CELL; HUMAN; HUMAN CELL; HYDROGEL; LASER DOPPLER FLOWMETRY; LEG ISCHEMIA; MICROVASCULATURE; MOUSE; NONHUMAN; PERFUSION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; THIXOTROPY; TISSUE ENGINEERING; TISSUE SCAFFOLD; VIRAL GENE DELIVERY SYSTEM; ANIMAL; C57BL MOUSE; DRUG EFFECTS; HINDLIMB; ISCHEMIA; MUSCLE; PATHOLOGY; REPERFUSION; TISSUE DISTRIBUTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ANIMALS; HINDLIMB; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; MICE, INBRED C57BL; MUSCLES; NANOFIBERS; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES; REPERFUSION; TISSUE DISTRIBUTION;

EID: 84966550455     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.04.032     Document Type: Article

References (42)

1. Hinchliffe R.J., Andros G., Apelqvist J., Bakker K., Friederichs S., Lammer J., et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab. Res. Rev. 2012, 28(Suppl. 1):179-217.
2. Cooke J.P., Losordo D.W. Modulating the vascular response to limb ischemia: angiogenic and cell therapies. Circ. Res. 2015, 116:1561-1578.
3. Simons M., Alitalo K., Annex B.H., Augustin H.G., Beam C., Berk B.C., et al. State-of-the-art methods for evaluation of angiogenesis and tissue vascularization: a scientific statement from the American Heart Association. Circ. Res. 2015, 116:e99-e132.
4. Cooke J.P., Chen Z. A compendium on peripheral arterial disease. Circ. Res. 2015, 116:1505-1508.
5. Mohsin S., Wu J.C., Sussman M.A. Predicting the future with stem cells. Circulation 2014, 129:136-138.
6. Yasumura E.G., Stilhano R.S., Samoto V.Y., Matsumoto P.K., de Carvalho L.P., Valero Lapchik V.B., et al. Treatment of mouse limb ischemia with an integrative hypoxia-responsive vector expressing the vascular endothelial growth factor gene. PLoS One 2012, 7:e33944.
7. Sun Q., Silva E.A., Wang A., Fritton J.C., Mooney D.J., Schaffler M.B., et al. Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. Pharm. Res. 2010, 27:264-271.
8. Sun Q., Chen R.R., Shen Y., Mooney D.J., Rajagopalan S., Grossman P.M. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm. Res. 2005, 22:1110-1116.
9. Giacca M., Zacchigna S. VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Gene Ther. 2012, 19:622-629.
10. Lu J., Pompili V.J., Das H. Neovascularization and hematopoietic stem cells. Cell Biochem. Biophys. 2013, 67:235-245.
11. Katare R., Stroemer P., Hicks C., Stevanato L., Patel S., Corteling R., et al. Clinical-grade human neural stem cells promote reparative neovascularization in mouse models of hindlimb ischemia. Arterioscler. Thromb. Vasc. Biol. 2014, 34:408-418.
12. Stewart D.J., Kutryk M.J., Fitchett D., Freeman M., Camack N., Su Y., et al. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol. Ther. 2009, 17:1109-1115.
13. Simon-Yarza T., Formiga F.R., Tamayo E., Pelacho B., Prosper F., Blanco-Prieto M.J. Vascular endothelial growth factor-delivery systems for cardiac repair: an overview. Theranostics 2012, 2:541-552.
14. Webber M.J., Han X., Murthy S.N., Rajangam K., Stupp S.I., Lomasney J.W. Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases. J. Tissue Eng. Regen. Med. 2010, 4:600-610.
15. Chen R.R., Snow J.K., Palmer J.P., Lin A.S., Duvall C.L., Guldberg R.E., et al. Host immune competence and local ischemia affects the functionality of engineered vasculature. Microcirculation 2007, 14:77-88.
16. Galler K.M., Aulisa L., Regan K.R., D'Souza R.N., Hartgerink J.D. Self-assembling multidomain peptide hydrogels: designed susceptibility to enzymatic cleavage allows enhanced cell migration and spreading. J. Am. Chem. Soc. 2010, 132:3217-3223.
17. Kumar V.A., Taylor N.L., Shi S., Wang B.K., Jalan A.A., Kang M.K., et al. Highly angiogenic peptide nanofibers. ACS Nano 2015, 9:860-868.
18. Kumar V.A., Taylor N.L., Shi S., Wickremasinghe N.C., D'Souza R.N., Hartgerink J.D. Self-assembling multidomain peptides tailor biological responses through biphasic release. Biomaterials 2015, 52:71-78.
19. Kumar V.A., Shi S., Wang B.K., Li I.C., Jalan A.A., Sarkar B., et al. Drug-triggered and cross-linked self-assembling nanofibrous hydrogels. J. Am. Chem. Soc. 2015, 137:4823-4830.
20. Wickremasinghe N.C., Kumar V.A., Hartgerink J.D. Two-step self-assembly of liposome-multidomain peptide nanofiber hydrogel for time-controlled release. Biomacromolecules 2014, 15:3587-3595.
21. Wang Y., Bakota E., Chang B.H., Entman M., Hartgerink J.D., Danesh F.R. Peptide nanofibers preconditioned with stem cell secretome are renoprotective. J. Am. Soc. Nephrol. 2011, 22:704-717.
22. Bakota E.L., Wang Y., Danesh F.R., Hartgerink J.D. Injectable multidomain peptide nanofiber hydrogel as a delivery agent for stem cell secretome. Biomacromolecules 2011, 12:1651-1657.
23. Bakota E.L., Aulisa L., Galler K.M., Hartgerink J.D. Enzymatic cross-linking of a nanofibrous peptide hydrogel. Biomacromolecules 2011, 12:82-87.
24. Liu Q., Chen Z., Terry T., McNatt J.M., Willerson J.T., Zoldhelyi P. Intra-arterial transplantation of adult bone marrow cells restores blood flow and regenerates skeletal muscle in ischemic limbs. Vasc. Endovasc. Surg. 2009, 43:433-443.
25. Webber M.J., Tongers J., Newcomb C.J., Marquardt K.T., Bauersachs J., Losordo D.W., et al. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:13438-13443.
26. Santulli G., Ciccarelli M., Palumbo G., Campanile A., Galasso G., Ziaco B., et al. In vivo properties of the proangiogenic peptide QK. J. Transl. Med. 2009, 7:41.
27. D'Andrea L.D., Iaccarino G., Fattorusso R., Sorriento D., Carannante C., Capasso D., et al. Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14215-14220.
28. Finetti F., Basile A., Capasso D., Di Gaetano S., Di Stasi R., Pascale M., et al. Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis. Biochem. Pharmacol. 2012, 84:303-311.
29. Wickremasinghe N.C., Kumar V.A., Shi S., Hartgerink J.D. Controlled angiogenesis in peptide nanofiber composite hydrogels. ACS Biomater. Sci. Eng. 2015, 1:845-854.
30. Fowkes F.G., Rudan D., Rudan I., Aboyans V., Denenberg J.O., McDermott M.M., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013, 382:1329-1340.
31. Semenza G.L. Oxygen sensing, homeostasis, and disease. N. Engl. J. Med. 2011, 365:537-547.
32. Leosco D., Rengo G., Iaccarino G., Sanzari E., Golino L., De Lisa G., et al. Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:471-480.
33. Rivard A., Fabre J.E., Silver M., Chen D., Murohara T., Kearney M., et al. Age-dependent impairment of angiogenesis. Circulation 1999, 99:111-120.
34. Wang H., Listrat A., Meunier B., Gueugneau M., Coudy-Gandilhon C., Combaret L., et al. Apoptosis in capillary endothelial cells in ageing skeletal muscle. Aging Cell 2014, 13:254-262.
35. Chan L.Y., Gunasekera S., Henriques S.T., Worth N.F., Le S.J., Clark R.J., et al. Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds. Blood 2011, 118:6709-6717.
36. Grochot-Przeczek A., Dulak J., Jozkowicz A. Therapeutic angiogenesis for revascularization in peripheral artery disease. Gene 2013, 525:220-228.
37. Phelps E.A., Garcia A.J. Engineering more than a cell: vascularization strategies in tissue engineering. Curr. Opin. Biotechnol. 2010, 21:704-709.
38. Phelps E.A., Landazuri N., Thule P.M., Taylor W.R., Garcia A.J. Bioartificial matrices for therapeutic vascularization. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3323-3328.
39. Terry T., Chen Z., Dixon R.A., Vanderslice P., Zoldhelyi P., Willerson J.T., et al. CD34(+)/M-cadherin(+) bone marrow progenitor cells promote arteriogenesis in ischemic hindlimbs of ApoE(-)/(-) mice. PLoS One 2011, 6:e20673.
40. Liu X., Terry T., Pan S., Yang Z., Willerson J.T., Dixon R.A., et al. Osmotic drug delivery to ischemic hindlimbs and perfusion of vasculature with microfil for micro-computed tomography imaging. J. Vis. Exp. 2013, (76):e50364. 10.3791/50364.
41. Capoccia B.J., Robson D.L., Levac K.D., Maxwell D.J., Hohm S.A., Neelamkavil M.J., et al. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood 2009, 113:5340-5351.
42. Prather W.R., Toren A., Meiron M., Ofir R., Tschope C., Horwitz E.M. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy 2009, 11:427-434.